Kirkland Theo N, Raz Eyal, Datta Sandip K
The Department of Pathology and Medicine, University of California-San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Vaccine. 2006 Jan 23;24(4):495-500. doi: 10.1016/j.vaccine.2005.07.092. Epub 2005 Aug 15.
Coccidioides immitis is endemic in the soil of the desert Southwest. It causes a respiratory infection that is usually mild, but can last months and may disseminate beyond the lung. Disseminated infections can be fatal or require life-long therapy. Development of an effective vaccine may be a successful method of preventing serious disease. In this paper, we show that immunostimulatory-oligodeoxynucleotides (ISS-ODN) are an effective adjuvant for a recombinant coccidioidal protein known as antigen 2/proline rich antigen. Protective immunity induced by this ISS-ODN-based vaccine requires IL-12, interferon-gamma and MHC Class II-restricted T-cells. Cytotoxic CD8 T-cells are not required. This study elucidates the mechanisms needed to elicit successful immunity against coccidioidomycosis, and holds promise for development of an effective coccidioidal vaccine against coccidioidomycosis.
粗球孢子菌在西南部沙漠地区的土壤中呈地方性流行。它可引发一种呼吸道感染,通常症状较轻,但可能持续数月,且可能扩散至肺部以外。播散性感染可能致命或需要终身治疗。研发一种有效的疫苗可能是预防严重疾病的成功方法。在本文中,我们表明免疫刺激寡脱氧核苷酸(ISS-ODN)是一种针对名为抗原2/富含脯氨酸抗原的重组球孢子菌蛋白的有效佐剂。这种基于ISS-ODN的疫苗诱导的保护性免疫需要IL-12、干扰素-γ和MHC II类限制性T细胞。不需要细胞毒性CD8 T细胞。这项研究阐明了引发针对球孢子菌病的成功免疫所需的机制,并为开发一种有效的抗球孢子菌病疫苗带来了希望。